Clinical Trials Browser

Phase 1/2 × Neuroendocrine Tumors × surufatinib × Clear all

Neuroendocrine Tumors

NCT04579757 2025-05-08

Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors

EndocrineGastrointestinalHead & NeckNETSarcomaThoracic

Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors, Small Cell Lung Carcinoma, Thyroid Carcinoma, Anaplastic

Clinical Trials

Open-label Study of Surufatinib in Japanese Patients

Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors